Pioglitazone and non-alcoholic fatty liver
Phase 2
Not yet recruiting
- Conditions
- on-alcoholic fatty liver.Fatty (change of) liver, not elsewhere classifiedK76.0
- Registration Number
- IRCT20210614051574N3
- Lead Sponsor
- Esfahan University of Medical Sciences
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Pending
- Sex
- All
- Target Recruitment
- 44
Inclusion Criteria
Age between 18 and 65 years
Candidate for bariatric surgery
Non-alcoholic fatty liver disease grade 3
Satisfaction with inclusion in the study
Exclusion Criteria
Daily consumption of more than 40 grams and 20 grams of alcohol for men and women, respectively
Having other liver diseases
Liver cancer
Taking hepatotoxic drugs
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Fatty liver grade. Timepoint: Before and 4 months after treatment. Method of measurement: Sonography.
- Secondary Outcome Measures
Name Time Method